Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
Deciphering which businesses can sustain their high growth rates is a challenge for even the most seasoned professionals, which is why we started StockStory. That said, here are three growth stocks expanding their competitive advantages.
Snowflake (SNOW)
One-Year Revenue Growth: +31.1%
Named after the unique architecture of its data warehouse which resembles a snowflake pattern, Snowflake (NYSE: SNOW) provides a cloud-based data platform that enables organizations to consolidate, analyze, and share data across multiple cloud providers.
Why Are We Backing SNOW?
- Winning new contracts that can potentially increase in value as its billings growth has averaged 31.4% over the last year
- Revenue outlook for the upcoming 12 months is outstanding and shows it’s on track to gain market share
- Fast payback periods on sales and marketing expenses allow the company to invest heavily and onboard many customers concurrently
Snowflake’s stock price of $239.75 implies a valuation ratio of 12.7x forward price-to-sales. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free.
Vita Coco (COCO)
One-Year Revenue Growth: +23.1%
Founded in 2004 followed by a 2021 IPO, The Vita Coco Company (NASDAQ: COCO) offers coconut water products that are a natural way to quench thirst.
Why Should You Buy COCO?
- Stellar 13.8% growth in unit sales over the past two years demonstrates the high demand for its products
- Earnings growth has trumped its peers over the last three years as its EPS has compounded at 52.4% annually
- Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures, and its rising returns show it’s making even more lucrative bets
At $75.00 per share, Vita Coco trades at 40.8x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
BrightSpring Health Services (BTSG)
One-Year Revenue Growth: +21%
Founded in 1974, BrightSpring Health Services (NASDAQ: BTSG) offers home health care, hospice, neuro-rehabilitation, and pharmacy services.
Why Is BTSG on Our Radar?
- Impressive 22.6% annual revenue growth over the last two years indicates it’s winning market share this cycle
- Economies of scale give it some operating leverage when demand rises
- Forecasted revenue growth of 14.2% for the next 12 months indicates its momentum over the last two years is sustainable
BrightSpring Health Services is trading at $59.56 per share, or 32.6x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
